Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

Unfortunately, these prescription ... handful of weight loss drug manufacturers issue copay cards that offer savings on expensive brand-name medications. To qualify, you usually need to have ...

Novo Nordisk's stock (NVO) rose more than 8% in Friday trading on news that the company's latest weight-loss product delivered favorable results. The new drug ... trial results need to be further ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs ... of a new Medicare initiative aimed at lowering prescription drug prices ...

Popular prescription ... Do people need to stay on the drug to prevent regaining the weight? That is what all the early data is telling us. They’ve done a number of studies and for people who have ...

“Weight-loss drugs can be hugely beneficial, but the risks need to ... The new GPhC rules state that prescribing pharmacies ...

Tired of weight-loss efforts ending in disappointment? Good news: Duke University’s Eric Westman, MD, has a twist on the keto ...